Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer-Reference-Cited by-同舟云学术

Phase 2 trial of erlotinib combined with cisplatin and radiotherapy in patients with locally advanced cervical cancer

Published:2014-03-10 Issue:8 Volume:120 Page:1187-1193
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Nogueira-Rodrigues Angelica¹,Moralez Giulliana¹,Grazziotin Rachele²,Carmo Claudio C.³,Small Isabele A.¹,Alves Flavia V.G.¹,Mamede Marcelo¹,Erlich Felipe²,Viegas Celia²,Triginelli Sergio A.⁴,Ferreira Carlos G.¹

Affiliation:

1. Coordination of Clinical Research; National Cancer Institute; Rio de Janeiro Brazil

2. Division of Radiation Oncology; National Cancer Institute; Rio de Janeiro Brazil

3. Division of Medical Oncology; National Cancer Institute; Rio de Janeiro Brazil

4. Division of Women's Health; Federal University of Minas Gerais; Belo Horizonte Brazil

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.28471/fullpdf

Reference36 articles.

1. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005

2. Human papillomaviruses as therapeutic targets in human cancer;Hellner;J Clin Oncol,2011

3. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix;Duenas-Gonzalez;J Clin Oncol,2011

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Investigational Drug’s Targeting Various Molecular Pathways for Treatment of Cervical Cancer: Current Status and Future Prospects;Cancer Investigation;2024-07-05

2. Multifaceted role of erlotinib in various cancer: nanotechnology intervention, patent landscape, and advancements in clinical trials;Medical Oncology;2024-06-12

3. New clinical trial design in precision medicine: discovery, development and direction;Signal Transduction and Targeted Therapy;2024-03-04

4. Molecular mechanisms augmenting resistance to current therapies in clinics among cervical cancer patients;Medical Oncology;2023-04-15

5. Drug repositioning via host-pathogen protein-protein interactions for the treatment of cervical cancer;Frontiers in Oncology;2023-01-25